Formerra has announced a significant agreement with GEON Performance Solutions that establishes the company as the preferred distributor of Foster LLC medical compounds in Europe. This development, confirmed on January 29, 2026, enhances Formerra’s existing distribution capabilities in North and South America, allowing the company to cater to healthcare customers across multiple regions with essential medical-grade materials.
The partnership builds on GEON’s acquisition of Foster in January 2025. It reinforces Formerra’s long-standing collaboration with GEON in providing flexible and rigid PVC and filled polypropylene materials. With this agreement, Formerra aims to leverage its expertise to support European healthcare manufacturers who require specialized compounds.
Kelly Wessner, Vice President of Key Accounts at Formerra, stated, “Bringing Foster’s medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments.” This strategic move aligns with the company’s mission to meet the high standards demanded by medical device manufacturers.
Enhancing Healthcare Solutions Across Europe
The Foster portfolio includes highly engineered formulations designed for stringent applications, such as radiopaque compounds and materials that meet USP Class VI requirements, while also aligning with ISO 10993 standards. These products are vital for critical healthcare applications, including implantable devices and other specialized uses that demand reliability and safety.
Arthur Adams, Chief Commercial Officer at GEON, emphasized the importance of this expansion by stating, “Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world’s most dynamic medical device markets.” This collaboration not only reinforces their commitment to innovation but also ensures that healthcare providers have access to the best materials available in the industry.
In addition to expanding product offerings, Formerra is well-positioned to provide customers with in-depth regulatory knowledge and efficient logistics solutions throughout Europe. This expertise is particularly crucial given the complex regulatory landscape that healthcare manufacturers navigate.
Upcoming Exhibition at MD&M West
Formerra will showcase its expanded offerings at the upcoming MD&M West event, taking place in Anaheim, California, from February 3 to 5, 2026. Attendees can visit Formerra at Booth 2266 to learn more about the newly available Foster medical compounds and how they can benefit their manufacturing processes.
This strategic agreement not only highlights Formerra’s commitment to enhancing its product portfolio but also underscores the growing demand for advanced medical materials in Europe. With proven solutions and a strong partnership with GEON, Formerra is poised to make a significant impact in the healthcare sector across the continent.
